Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Alexander Leads Bipartisan Support for Accelerated FDA Reviews


 

On Aug. 2, the U.S. Senate passed bipartisan legislation led by health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) intended to speed approval of safe drugs and medical devices.

Alexander said: "The Senate has sent to the president's desk legislation that will speed cures and treatments into patients' medicine cabinets. The first step was last year's passage of 21st Century Cures to spur medical research, and this is the next step -- ensuring patients see the benefits of those research advancements."

The legislation includes four different user fee agreements that must be reauthorized by Sept. 30. The bill is virtually identical to legislation overwhelmingly approved by the Senate's health committee on May 11. This legislation will reauthorize the authority for the Food and Drug Administration (FDA) to accept user fees - paid by manufacturers of drugs and medical devices - that account for $8 to $9 billion over 5 years and is over a quarter of all FDA funding. The reauthorizations are based on recommendations from industry and FDA after a public process.

Over the last year and a half, the HELP Committee that Alexander chairs has held 15 bipartisan briefings, including some with the House Energy and Commerce Committee, to hear from FDA and industry about the reauthorization. The HELP Committee held two bipartisan hearings, on March 21 and April 4, on the medical device and drug user fees. The committee held a markup on the bill on May 11, when two bipartisan amendments were adopted, and the committee overwhelmingly approved the bill -- voting 21 to 2.

The bill includes provisions from:

  • Sens. Isakson and Bennet to improve the medical device inspection process.
  • Sens. Hassan and Young to improve communication about abuse-deterrent opioid products.
  • Sens. Enzi and Franken to encourage medical device development for children, and make sure FDA has appropriate expertise to review devices for children.
  • Sens Roberts, Donnelly, and Burr to allow more appropriate classification of accessories used with medical devices.
  • Sens Collins, Franken, McCaskill, and Cotton to improve generic drug development and help lower prescription drug costs.
  • Sens. Hatch, Bennet, Burr, and Casey to improve access to clinical trials for all patients.
  • Sens. Bennet, Rubio, Van Hollen, and Gardner to increase the development of new drugs to treat pediatric cancers and other diseases.
 
Share:

Related Articles:


Recent Articles

Integrating AI in Healthcare

Technology has advanced to a point where AI in healthcare is increasingly common. Now the challenge is utilizing data in a way that is not only predictive but also prescriptive to improve health and outcomes.

Read More

AMA Advances New Principles to Put AI into Practice

AHIP isn't the only national organization focused on how AI might be effectively deployed to improve patient engagement, care and interaction with the broader healthcare system.

Read More

State of Technology

Nashville HIT leaders address challenges, accomplishments of the region's thriving healthcare IT market.

Read More

Helping Children and Athletes Breathe Easier

Experiencing shortness of breath during exercise can be extremely distressing, particularly when it occurs in a child, teen or young adult.

Read More

PHYSICIAN SPOTLIGHT: Between Medicine and Technology

When it comes to rolling out new systems, Neal Patel, MD, said listening to users and understanding concerns are critical to success.

Read More

Navigating the Risks of New Healthcare Technologies

New technologies in healthcare hold great promise, but with that promise come risks that must be considered and addressed.

Read More

Tech Talk

Recent news of note in Middle Tennessee's health tech sector.

Read More

Enhancing Access to Care through Technology

Innovative technology allows patients, health plans to schedule appointments online.

Read More

Reimaging Residency

A joint project between Vanderbilt and Ole Miss was one of eight selected by the American Medical Association to reimagine residency programming.

Read More

Tips & Traps: Expert Insights from NMGMA Leadership

NMGMA's president and president-elect share insights borne of experience to help practice managers enhance success.

Read More

Email Print
 
 

 

 


Tags:
FDA, HELP Committee, Lamar Alexander, U.S. Senate
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: